Glycomics/Glycobiology Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Glycomics Glycobiology Market: By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery and Development, Diagnostics, Others), By End Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, CROs, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

1. Executive Summary
2. Global Glycomics/Glycobiology Market Introduction
2.1. Global Glycomics/Glycobiology Market – Taxonomy
2.2. Global Glycomics/Glycobiology Market –Definitions
2.2.1. By Product
2.2.2. By Application
2.2.3. By End Use
2.2.4. By Region
3. Global Glycomics/Glycobiology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Glycomics/Glycobiology Market Dynamic Factors – Impact Analysis
3.6. Global Glycomics/Glycobiology Market – Competition Landscape
4. Global Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Glycomics/Glycobiology Market, By Product, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1. Enzymes
5.1.1. Glycosidases
5.1.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4. Market Opportunity Analysis
5.1.5. Neuraminidases
5.1.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.8. Market Opportunity Analysis
5.1.9. Glycosyltransferases
5.1.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.12. Market Opportunity Analysis
5.1.13. Sialytransferases
5.1.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.16. Market Opportunity Analysis
5.1.17. Others
5.1.18. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.19. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.20. Market Opportunity Analysis
5.2. Kits
5.2.1. Glycan Labelling Kits
5.2.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.2.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.4. Market Opportunity Analysis
5.2.5. Glycan Purification Kits
5.2.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.2.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.8. Market Opportunity Analysis
5.2.9. Glycan Releases Kits
5.2.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.2.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.12. Market Opportunity Analysis
5.2.13. Others
5.2.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.2.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.16. Market Opportunity Analysis
5.3. Reagents
5.3.1. Glycoporteins
5.3.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.3.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.4. Market Opportunity Analysis
5.3.5. Monosaccharides
5.3.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.3.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.8. Market Opportunity Analysis
5.3.9. Oligosaccharides
5.3.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.3.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.12. Market Opportunity Analysis
5.3.13. Others
5.3.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.3.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.16. Market Opportunity Analysis
5.4. Instruments
5.4.1. Mass Spectrometers
5.4.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.4.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.4. Market Opportunity Analysis
5.4.5. HPLC
5.4.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.4.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.8. Market Opportunity Analysis
5.4.9. MALDI-TOF
5.4.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.4.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.12. Market Opportunity Analysis
5.4.13. Array Systems
5.4.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.4.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.16. Market Opportunity Analysis
5.4.17. Others
5.4.18. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.4.19. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.20. Market Opportunity Analysis
6. Global Glycomics/Glycobiology Market, By Application, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.1. Drug Discovery and Development
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Diagnostics
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Glycomics/Glycobiology Market, By End User, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.1. Academic & Research Institutes
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Pharmaceutical & Biotechnology Companies
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. CROs
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Glycomics/Glycobiology Market Forecast, By Region, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, By End User and Region, 2022- 2028
9. North America Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
9.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Enzymes
9.1.1.1. Glycosidases
9.1.1.2. Neuraminidases
9.1.1.3. Glycosyltransferases
9.1.1.4. Sialytransferases
9.1.1.5. Others
9.1.2. Kits
9.1.2.1. Glycan Labelling Kits
9.1.2.2. Glycan Purification Kits
9.1.2.3. Glycan Releases Kits
9.1.2.4. Others
9.1.3. Reagents
9.1.3.1. Glycoporteins
9.1.3.2. Monosaccharides
9.1.3.3. Oligosaccharides
9.1.3.4. Others
9.1.4. Instruments
9.1.4.1. Mass Spectrometers
9.1.4.2. HPLC
9.1.4.3. MALDI-TOF
9.1.4.4. Array Systems
9.1.4.5. Others
9.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Drug Discovery & Development
9.2.2. Diagnostics
9.2.3. Others
9.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Academic & Research Institutes
9.3.2. Pharmaceutical & Biotechnology Companies
9.3.3. CROs
9.3.4. Others
9.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028
9.6. North America Glycomics/Glycobiology Market Dynamics – Trends
10. Europe Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
10.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Enzymes
10.1.1.1. Glycosidases
10.1.1.2. Neuraminidases
10.1.1.3. Glycosyltransferases
10.1.1.4. Sialytransferases
10.1.1.5. Others
10.1.2. Kits
10.1.2.1. Glycan Labelling Kits
10.1.2.2. Glycan Purification Kits
10.1.2.3. Glycan Releases Kits
10.1.2.4. Others
10.1.3. Reagents
10.1.3.1. Glycoporteins
10.1.3.2. Monosaccharides
10.1.3.3. Oligosaccharides
10.1.3.4. Others
10.1.4. Instruments
10.1.4.1. Mass Spectrometers
10.1.4.2. HPLC
10.1.4.3. MALDI-TOF
10.1.4.4. Array Systems
10.1.4.5. Others
10.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Drug Discovery & Development
10.2.2. Diagnostics
10.2.3. Others
10.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Academic & Research Institutes
10.3.2. Pharmaceutical & Biotechnology Companies
10.3.3. CROs
10.3.4. Others
10.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028
10.6. Europe Glycomics/Glycobiology Market Dynamics – Trends
11. Asia-Pacific Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
11.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Enzymes
11.1.1.1. Glycosidases
11.1.1.2. Neuraminidases
11.1.1.3. Glycosyltransferases
11.1.1.4. Sialytransferases
11.1.1.5. Others
11.1.2. Kits
11.1.2.1. Glycan Labelling Kits
11.1.2.2. Glycan Purification Kits
11.1.2.3. Glycan Releases Kits
11.1.2.4. Others
11.1.3. Reagents
11.1.3.1. Glycoporteins
11.1.3.2. Monosaccharides
11.1.3.3. Oligosaccharides
11.1.3.4. Others
11.1.4. Instruments
11.1.4.1. Mass Spectrometers
11.1.4.2. HPLC
11.1.4.3. MALDI-TOF
11.1.4.4. Array Systems
11.1.4.5. Others
11.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Drug Discovery & Development
11.2.2. Diagnostics
11.2.3. Others
11.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Academic & Research Institutes
11.3.2. Pharmaceutical & Biotechnology Companies
11.3.3. CROs
11.3.4. Others
11.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028
11.6. Asia-Pacific Glycomics/Glycobiology Market Dynamics – Trends
12. Latin America Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
12.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Enzymes
12.1.1.1. Glycosidases
12.1.1.2. Neuraminidases
12.1.1.3. Glycosyltransferases
12.1.1.4. Sialytransferases
12.1.1.5. Others
12.1.2. Kits
12.1.2.1. Glycan Labelling Kits
12.1.2.2. Glycan Purification Kits
12.1.2.3. Glycan Releases Kits
12.1.2.4. Others
12.1.3. Reagents
12.1.3.1. Glycoporteins
12.1.3.2. Monosaccharides
12.1.3.3. Oligosaccharides
12.1.3.4. Others
12.1.4. Instruments
12.1.4.1. Mass Spectrometers
12.1.4.2. HPLC
12.1.4.3. MALDI-TOF
12.1.4.4. Array Systems
12.1.4.5. Others
12.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Drug Discovery & Development
12.2.2. Diagnostics
12.2.3. Others
12.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Academic & Research Institutes
12.3.2. Pharmaceutical & Biotechnology Companies
12.3.3. CROs
12.3.4. Others
12.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028
12.6. Latin America Glycomics/Glycobiology Market Dynamics – Trends
13. Middle East and Africa Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
13.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Enzymes
13.1.1.1. Glycosidases
13.1.1.2. Neuraminidases
13.1.1.3. Glycosyltransferases
13.1.1.4. Sialytransferases
13.1.1.5. Others
13.1.2. Kits
13.1.2.1. Glycan Labelling Kits
13.1.2.2. Glycan Purification Kits
13.1.2.3. Glycan Releases Kits
13.1.2.4. Others
13.1.3. Reagents
13.1.3.1. Glycoporteins
13.1.3.2. Monosaccharides
13.1.3.3. Oligosaccharides
13.1.3.4. Others
13.1.4. Instruments
13.1.4.1. Mass Spectrometers
13.1.4.2. HPLC
13.1.4.3. MALDI-TOF
13.1.4.4. Array Systems
13.1.4.5. Others
13.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Drug Discovery & Development
13.2.2. Diagnostics
13.2.3. Others
13.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.3.1. Academic & Research Institutes
13.3.2. Pharmaceutical & Biotechnology Companies
13.3.3. CROs
13.3.4. Others
13.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028
13.6. MEA Glycomics/Glycobiology Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.1.1. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
14.1.2. Thermo Fisher Scientific, Inc. (US)
14.1.3. Merck KGaA (Germany)
14.1.4. Agilent Technologies (US)
14.1.5. Bruker Corporation (US)
14.1.6. New England Biolabs (US)
14.1.7. Danaher Corporation  (US)
14.1.8. Shimadzu Corporation (Japan)
14.1.9. Takara Bio, Inc. (Japan)
14.1.10. Waters Corporation (US)
14.1.11. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
14.1.12. RayBiotech (US)
14.1.13. Z Biotech (US)
14.1.14. Chemily Glycoscience (US)
14.1.15. Dextra Laboratories (UK)
14.1.16. Lectenz Bio (US)
14.1.17. Ludger Ltd. (UK)
14.1.18. Asparia Glycomics S.L. (Spain)
14.1.19. Bio-Techne (US)
14.1.20. Other Companies
15. Research Methodology
16. Key Assumptions and Acronyms

Frequently Asked Questions


Report

Company Profile

  • Thermo Fisher Scientific, Inc. (US)
  • Merck KGaA (Germany)
  • Agilent Technologies (US)
  • Bruker Corporation (US)
  • New England Biolabs (US)
  • Danaher Corporation  (US)
  • Shimadzu Corporation (Japan)
  • Takara Bio, Inc. (Japan)
  • Waters Corporation (US)
  • S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • RayBiotech (US)
  • Z Biotech (US)
  • Chemily Glycoscience (US)
  • Dextra Laboratories (UK)
  • Lectenz Bio (US)
  • Ludger Ltd. (UK)
  • Asparia Glycomics S.L. (Spain)
  • Bio-Techne (US)

Description

1. Executive Summary
2. Global Glycomics/Glycobiology Market Introduction
2.1. Global Glycomics/Glycobiology Market – Taxonomy
2.2. Global Glycomics/Glycobiology Market –Definitions
2.2.1. By Product
2.2.2. By Application
2.2.3. By End Use
2.2.4. By Region
3. Global Glycomics/Glycobiology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Glycomics/Glycobiology Market Dynamic Factors – Impact Analysis
3.6. Global Glycomics/Glycobiology Market – Competition Landscape
4. Global Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Glycomics/Glycobiology Market, By Product, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1. Enzymes
5.1.1. Glycosidases
5.1.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4. Market Opportunity Analysis
5.1.5. Neuraminidases
5.1.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.8. Market Opportunity Analysis
5.1.9. Glycosyltransferases
5.1.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.12. Market Opportunity Analysis
5.1.13. Sialytransferases
5.1.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.16. Market Opportunity Analysis
5.1.17. Others
5.1.18. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.19. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.20. Market Opportunity Analysis
5.2. Kits
5.2.1. Glycan Labelling Kits
5.2.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.2.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.4. Market Opportunity Analysis
5.2.5. Glycan Purification Kits
5.2.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.2.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.8. Market Opportunity Analysis
5.2.9. Glycan Releases Kits
5.2.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.2.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.12. Market Opportunity Analysis
5.2.13. Others
5.2.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.2.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.16. Market Opportunity Analysis
5.3. Reagents
5.3.1. Glycoporteins
5.3.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.3.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.4. Market Opportunity Analysis
5.3.5. Monosaccharides
5.3.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.3.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.8. Market Opportunity Analysis
5.3.9. Oligosaccharides
5.3.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.3.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.12. Market Opportunity Analysis
5.3.13. Others
5.3.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.3.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.16. Market Opportunity Analysis
5.4. Instruments
5.4.1. Mass Spectrometers
5.4.2. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.4.3. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.4. Market Opportunity Analysis
5.4.5. HPLC
5.4.6. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.4.7. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.8. Market Opportunity Analysis
5.4.9. MALDI-TOF
5.4.10. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.4.11. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.12. Market Opportunity Analysis
5.4.13. Array Systems
5.4.14. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.4.15. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.16. Market Opportunity Analysis
5.4.17. Others
5.4.18. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.4.19. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.20. Market Opportunity Analysis
6. Global Glycomics/Glycobiology Market, By Application, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.1. Drug Discovery and Development
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Diagnostics
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Glycomics/Glycobiology Market, By End User, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.1. Academic & Research Institutes
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Pharmaceutical & Biotechnology Companies
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. CROs
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Glycomics/Glycobiology Market Forecast, By Region, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, By End User and Region, 2022- 2028
9. North America Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
9.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Enzymes
9.1.1.1. Glycosidases
9.1.1.2. Neuraminidases
9.1.1.3. Glycosyltransferases
9.1.1.4. Sialytransferases
9.1.1.5. Others
9.1.2. Kits
9.1.2.1. Glycan Labelling Kits
9.1.2.2. Glycan Purification Kits
9.1.2.3. Glycan Releases Kits
9.1.2.4. Others
9.1.3. Reagents
9.1.3.1. Glycoporteins
9.1.3.2. Monosaccharides
9.1.3.3. Oligosaccharides
9.1.3.4. Others
9.1.4. Instruments
9.1.4.1. Mass Spectrometers
9.1.4.2. HPLC
9.1.4.3. MALDI-TOF
9.1.4.4. Array Systems
9.1.4.5. Others
9.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Drug Discovery & Development
9.2.2. Diagnostics
9.2.3. Others
9.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Academic & Research Institutes
9.3.2. Pharmaceutical & Biotechnology Companies
9.3.3. CROs
9.3.4. Others
9.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028
9.6. North America Glycomics/Glycobiology Market Dynamics – Trends
10. Europe Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
10.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Enzymes
10.1.1.1. Glycosidases
10.1.1.2. Neuraminidases
10.1.1.3. Glycosyltransferases
10.1.1.4. Sialytransferases
10.1.1.5. Others
10.1.2. Kits
10.1.2.1. Glycan Labelling Kits
10.1.2.2. Glycan Purification Kits
10.1.2.3. Glycan Releases Kits
10.1.2.4. Others
10.1.3. Reagents
10.1.3.1. Glycoporteins
10.1.3.2. Monosaccharides
10.1.3.3. Oligosaccharides
10.1.3.4. Others
10.1.4. Instruments
10.1.4.1. Mass Spectrometers
10.1.4.2. HPLC
10.1.4.3. MALDI-TOF
10.1.4.4. Array Systems
10.1.4.5. Others
10.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Drug Discovery & Development
10.2.2. Diagnostics
10.2.3. Others
10.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Academic & Research Institutes
10.3.2. Pharmaceutical & Biotechnology Companies
10.3.3. CROs
10.3.4. Others
10.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028
10.6. Europe Glycomics/Glycobiology Market Dynamics – Trends
11. Asia-Pacific Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
11.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Enzymes
11.1.1.1. Glycosidases
11.1.1.2. Neuraminidases
11.1.1.3. Glycosyltransferases
11.1.1.4. Sialytransferases
11.1.1.5. Others
11.1.2. Kits
11.1.2.1. Glycan Labelling Kits
11.1.2.2. Glycan Purification Kits
11.1.2.3. Glycan Releases Kits
11.1.2.4. Others
11.1.3. Reagents
11.1.3.1. Glycoporteins
11.1.3.2. Monosaccharides
11.1.3.3. Oligosaccharides
11.1.3.4. Others
11.1.4. Instruments
11.1.4.1. Mass Spectrometers
11.1.4.2. HPLC
11.1.4.3. MALDI-TOF
11.1.4.4. Array Systems
11.1.4.5. Others
11.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Drug Discovery & Development
11.2.2. Diagnostics
11.2.3. Others
11.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Academic & Research Institutes
11.3.2. Pharmaceutical & Biotechnology Companies
11.3.3. CROs
11.3.4. Others
11.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028
11.6. Asia-Pacific Glycomics/Glycobiology Market Dynamics – Trends
12. Latin America Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
12.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Enzymes
12.1.1.1. Glycosidases
12.1.1.2. Neuraminidases
12.1.1.3. Glycosyltransferases
12.1.1.4. Sialytransferases
12.1.1.5. Others
12.1.2. Kits
12.1.2.1. Glycan Labelling Kits
12.1.2.2. Glycan Purification Kits
12.1.2.3. Glycan Releases Kits
12.1.2.4. Others
12.1.3. Reagents
12.1.3.1. Glycoporteins
12.1.3.2. Monosaccharides
12.1.3.3. Oligosaccharides
12.1.3.4. Others
12.1.4. Instruments
12.1.4.1. Mass Spectrometers
12.1.4.2. HPLC
12.1.4.3. MALDI-TOF
12.1.4.4. Array Systems
12.1.4.5. Others
12.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Drug Discovery & Development
12.2.2. Diagnostics
12.2.3. Others
12.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Academic & Research Institutes
12.3.2. Pharmaceutical & Biotechnology Companies
12.3.3. CROs
12.3.4. Others
12.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028
12.6. Latin America Glycomics/Glycobiology Market Dynamics – Trends
13. Middle East and Africa Glycomics/Glycobiology Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
13.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Enzymes
13.1.1.1. Glycosidases
13.1.1.2. Neuraminidases
13.1.1.3. Glycosyltransferases
13.1.1.4. Sialytransferases
13.1.1.5. Others
13.1.2. Kits
13.1.2.1. Glycan Labelling Kits
13.1.2.2. Glycan Purification Kits
13.1.2.3. Glycan Releases Kits
13.1.2.4. Others
13.1.3. Reagents
13.1.3.1. Glycoporteins
13.1.3.2. Monosaccharides
13.1.3.3. Oligosaccharides
13.1.3.4. Others
13.1.4. Instruments
13.1.4.1. Mass Spectrometers
13.1.4.2. HPLC
13.1.4.3. MALDI-TOF
13.1.4.4. Array Systems
13.1.4.5. Others
13.2. Application Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Drug Discovery & Development
13.2.2. Diagnostics
13.2.3. Others
13.3. End User Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.3.1. Academic & Research Institutes
13.3.2. Pharmaceutical & Biotechnology Companies
13.3.3. CROs
13.3.4. Others
13.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Glycomics/Glycobiology Market – Opportunity Analysis Index, By Glycomics/Glycobiology, End User And Country, 2022- 2028
13.6. MEA Glycomics/Glycobiology Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.1.1. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
14.1.2. Thermo Fisher Scientific, Inc. (US)
14.1.3. Merck KGaA (Germany)
14.1.4. Agilent Technologies (US)
14.1.5. Bruker Corporation (US)
14.1.6. New England Biolabs (US)
14.1.7. Danaher Corporation  (US)
14.1.8. Shimadzu Corporation (Japan)
14.1.9. Takara Bio, Inc. (Japan)
14.1.10. Waters Corporation (US)
14.1.11. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
14.1.12. RayBiotech (US)
14.1.13. Z Biotech (US)
14.1.14. Chemily Glycoscience (US)
14.1.15. Dextra Laboratories (UK)
14.1.16. Lectenz Bio (US)
14.1.17. Ludger Ltd. (UK)
14.1.18. Asparia Glycomics S.L. (Spain)
14.1.19. Bio-Techne (US)
14.1.20. Other Companies
15. Research Methodology
16. Key Assumptions and Acronyms

Reviews

There are no reviews yet.

Be the first to review “Glycomics/Glycobiology Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX